Illinois Compiled Statutes 215 ILCS 5/356z.50 – Comprehensive cancer testing
Current as of: 2024 | Check for updates
|
Other versions
(a) As used in this Section:
“Comprehensive cancer testing” includes, but is not limited to, the following forms of testing:
(1) Targeted cancer gene panels.
(2) Whole-exome genome testing.
(3) Whole-genome sequencing.
(4) RNA sequencing.
(5) Tumor mutation burden.
“Testing of blood or constitutional tissue for cancer predisposition testing” includes, but is not limited to, the following forms of testing:
(1) Targeted cancer gene panels.
(2) Whole-exome genome testing.
(3) Whole-genome sequencing.
(b) An individual or group policy of accident and health insurance or managed care plan that is amended, delivered, issued, or renewed on or after January 1, 2022 (the effective date of Public Act 102-589) shall provide coverage for medically necessary comprehensive cancer testing and testing of blood or constitutional tissue for cancer predisposition testing as determined by a physician licensed to practice medicine in all of its branches.
“Comprehensive cancer testing” includes, but is not limited to, the following forms of testing:
Terms Used In Illinois Compiled Statutes 215 ILCS 5/356z.50
- individual: shall include every infant member of the species homo sapiens who is born alive at any stage of development. See Illinois Compiled Statutes 5 ILCS 70/1.36
(1) Targeted cancer gene panels.
(2) Whole-exome genome testing.
(3) Whole-genome sequencing.
(4) RNA sequencing.
(5) Tumor mutation burden.
“Testing of blood or constitutional tissue for cancer predisposition testing” includes, but is not limited to, the following forms of testing:
(1) Targeted cancer gene panels.
(2) Whole-exome genome testing.
(3) Whole-genome sequencing.
(b) An individual or group policy of accident and health insurance or managed care plan that is amended, delivered, issued, or renewed on or after January 1, 2022 (the effective date of Public Act 102-589) shall provide coverage for medically necessary comprehensive cancer testing and testing of blood or constitutional tissue for cancer predisposition testing as determined by a physician licensed to practice medicine in all of its branches.